gellerbiopharm.com
Geller BiopharmGeller Biopharm Inc Advises Ovid on Licensing Agreement with Lundbeck. More news ». Read full release ». Sign up for our email list. Get a digital copy of our PDF presentation.
http://www.gellerbiopharm.com/
Geller Biopharm Inc Advises Ovid on Licensing Agreement with Lundbeck. More news ». Read full release ». Sign up for our email list. Get a digital copy of our PDF presentation.
http://www.gellerbiopharm.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Tuesday
LOAD TIME
Contact Privacy Inc. Customer 0126139153
Contact Privacy Inc. Customer 0126139153
96 M●●●● Ave
To●●to , ON, M6K 3M1
CA
View this contact
Contact Privacy Inc. Customer 0126139153
Contact Privacy Inc. Customer 0126139153
96 M●●●● Ave
To●●to , ON, M6K 3M1
CA
View this contact
Contact Privacy Inc. Customer 0126139153
Contact Privacy Inc. Customer 0126139153
96 M●●●● Ave
To●●to , ON, M6K 3M1
CA
View this contact
13
YEARS
2
MONTHS
26
DAYS
TUCOWS DOMAINS INC.
WHOIS : whois.tucows.com
REFERRED : http://domainhelp.opensrs.net
PAGES IN
THIS WEBSITE
8
SSL
EXTERNAL LINKS
1
SITE IP
192.169.136.221
LOAD TIME
0 sec
SCORE
6.2
Geller Biopharm | gellerbiopharm.com Reviews
https://gellerbiopharm.com
Geller Biopharm Inc Advises Ovid on Licensing Agreement with Lundbeck. More news ». Read full release ». Sign up for our email list. Get a digital copy of our PDF presentation.
Geller Biopharm Transactions: Current Deals
http://www.gellerbiopharm.com/transactions_current.html
We currently represent several high quality biotech companies in multi-track licensing and M&A engagements, including:. A company with a unique LAMA for Asthma and COPD with Positive Ph II Data, available for licensing. A company with a Ph IIb antibody-based therapy for the treatment of Shiga Toxin induced Hemolytic Uremic Syndrome (sHUS), an ultra-orphan disorder, available for licensing. A company with a novel Ph II mAb to treat Primary Biliary Cirrhosis and Crohn s Disease, available for licensing.
Geller Biopharm Services: Financing
http://www.gellerbiopharm.com/services_financing.html
Vast experience in private and public financing, including venture and crossover financings, PIPES, Registered Directs, Secondaries and IPO's. Long-term personal relationships with a broad array of US and European public and private investors. Based on many years of experience, Geller Biopharm has outstanding capabilities in positioning and presenting companies to the investor audience for financing. Sign up for our email list. Get a digital copy of our PDF presentation.
Geller Biopharm
http://www.gellerbiopharm.com/index.html
Geller Biopharm Inc Advises Ovid on Licensing Agreement with Lundbeck. More news ». Read full release ». Sign up for our email list. Get a digital copy of our PDF presentation.
Geller Biopharm News: Press Releases
http://www.gellerbiopharm.com/news_press_releases.html
Geller Biopharm Inc Advises Ovid on Licensing Agreement with Lundbeck. April 15, 2015. Lundbeck and Ovid Therapeutics Announce Exclusive Worldwide Licensing Agreement for Gaboxadol Ovid plans to commence Phase 2 trials in two orphan neurological indications, Angelman Syndrome and Fragile X Syndrome, in 2016 NEW YORK and VALBY, Denmark- (BUSINESS WIRE)- H. Lundbeck A/S (Lundbeck; LUN.CO, LUN DC, HLUYY), A global pharmaceutical company specialized in brain diseases. We are happy with this agreement allowin...
Geller Biopharm Services: LM&A
http://www.gellerbiopharm.com/services_lm&a.html
Licensing, Mergers and Acquisitions. The senior members of Geller Biopharm are personally involved in every stage of the engagement, from the initial meeting to closing dinner. Based on many years of experience, Geller Biopharm has outstanding capabilities in positioning and presenting companies to increase the receptiveness by the appropriate target audience. Our team has enormous breadth and depth in its industry contacts with senior executives, heads of business and research development.
TOTAL PAGES IN THIS WEBSITE
8
Geller Biopharm News: Press Releases
http://www.gellerbp.com/news_press_releases.html
Geller Biopharm Inc Advises Ovid on Licensing Agreement with Lundbeck. April 15, 2015. Lundbeck and Ovid Therapeutics Announce Exclusive Worldwide Licensing Agreement for Gaboxadol Ovid plans to commence Phase 2 trials in two orphan neurological indications, Angelman Syndrome and Fragile X Syndrome, in 2016 NEW YORK and VALBY, Denmark- (BUSINESS WIRE)- H. Lundbeck A/S (Lundbeck; LUN.CO, LUN DC, HLUYY), A global pharmaceutical company specialized in brain diseases. We are happy with this agreement allowin...
TOTAL LINKS TO THIS WEBSITE
1
Geller Associates custom cabinetry and woodwork home page
We are a custom cabinetmaking shop in Acton, Massachusetts. In business for over 30 years, our expertise encompasses the design and building of kitchen and bathroom cabinetry, house doors, built-in units, and furniture. We design interactively with our customers. Free DHTML scripts provided by Dynamic Drive.
Web hosting provider - Bluehost.com - domain hosting - PHP Hosting - cheap web hosting - Frontpage Hosting E-Commerce Web Hosting Bluehost
Web Hosting - courtesy of www.bluehost.com.
Geller Biopharm
Geller Biopharm Inc Advises Ovid on Licensing Agreement with Lundbeck. More news ». Read full release ». Sign up for our email list. Get a digital copy of our PDF presentation.
Gellér B. István - A növekvõ város
UNDER CONSTRUCTION
Geller Biopharm
February 20, 2018. Geller Biopharm Inc. Represents Amunix for Celgene License. More news ». Read full release ». Sign up for our email list. Get a digital copy of our PDF presentation.
Geller Butchers
Welcome To Geller Butchers. Suppliers of premium quality, locally reared fresh meats. We also have a vast range of home cooked meats, pies, pastries and home made sausages. We are a traditional english family run butchers, established in 1966 by Jack Geller, now under the ownership of the Warnes family, master butchers since 1970. We supply premium quality meats to restaurants, hotels, public houses and the public 6 days a week, both locally in Colchester and throughout Essex! New Season, New Menu.
gellercapitalviews.blogspot.com
Geller Capital Views
Geller Capital Views is written to be a clear and concise report on the markets along with an analysis of the risks and opportunities and what they mean to the portfolios of Geller Capital Mgmt LLC. Visit GellerCapital.com or email info@gellercapital.com for further information. Friday, January 09, 2009. Your Mail/Cry of Marvin Dale. I would like to appeal to you confidentialy to assist me concerning my late fathers Fund which he deposited in a financial firm, he has the sum of nine million, two hundred ...